HCA — HCA Healthcare, Inc.

HCA Healthcare Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Increased by 4.3% year-over-year.
• Adjusted EBITDA: Grew by almost 2% compared to Q1 2025.
• Diluted Earnings Per Share (EPS): Adjusted EPS rose approximately 11% year-over-year.
• Same-Facility Volume:
  • Admissions up 0.9%
  • Equivalent admissions up 1.3%
  • Inpatient surgeries down 0.3%
  • Outpatient surgeries down 1.7%
  • Emergency Room (ER) visits up 0.3%
• Impact of Weather and Respiratory Season: Estimated $180 million negative impact from a milder respiratory season and winter storms.
• Medicaid Supplemental Payment Programs: Net benefits were approximately $200 million, significantly exceeding initial expectations of $80 million.

2. Strategic Updates and Business Highlights

• Resiliency Plan: Focused on cost savings, enhancing network execution, and strengthening organizational capabilities, which are expected to continue benefiting the company.
• Digital Transformation and AI Initiatives: Progress made with key initiatives being rolled out to more facilities, aimed at improving quality, safety, and operational efficiency.
• Network Development: Expanded overall sites of care by over 4%, increased hospital beds by nearly 1%, and enhanced emergency room capacity by 4%.
• Capital Expenditures: Totaled $1.1 billion in Q1, with ongoing investments in outpatient facility acquisitions.

3. Forward Guidance and Outlook

• Volume Growth Guidance: Reaffirmed expectations of 2% to 3% volume growth for the remainder of 2026, with confidence in recovering volumes post-January.
• Adjusted EBITDA Guidance: Full-year guidance remains unchanged despite first-quarter dynamics, with expectations of $600 million to $900 million impact from exchange-related adjustments.
• Medicaid Program Updates: Positive outlook on potential approvals for Florida’s Medicaid program, which could yield significant additional revenues.

4. Bad News, Challenges, or Points of Concern

• Volume Shortfalls: The company experienced a significant decline in respiratory-related admissions and ER visits, attributed to a milder respiratory season and adverse weather conditions.
• Payer Mix Concerns: Notable shifts in the payer mix due to changes in health insurance exchanges, with a 15% decline in exchange equivalent admissions and a 16% increase in uninsured admissions.
• Operational Challenges: Increased costs in certain markets, particularly in North Carolina, due to workforce shortages impacting service delivery and profitability.
• Denials and Underpayments: Continued high levels of denials and underpayments from payers, particularly in Medicare Advantage, despite efforts to improve revenue cycle management.

5. Notable Q&A Insights

• Impact of Weather and Respiratory Season: Management clarified that the weather-related volume impacts were primarily temporal and not expected to recur.
• Medicaid Conversion Slowdown: The slowdown in Medicaid conversions was noted as potentially linked to hesitance among individuals to fill out applications, with no clear indication if this trend would persist.
• Exchange Patient Dynamics: The complexity of tracking exchange patients during grace periods was discussed, with management indicating that they are monitoring the situation closely as it evolves.
• Future Capital Projects: Management expressed confidence in ongoing capital projects and acquisitions, particularly in outpatient care, as a growth lever moving forward.

Overall, HCA Healthcare demonstrated resilience in navigating a challenging first quarter, with strategic initiatives in place to enhance operational efficiency and patient care, while also addressing the impacts of external factors on volume and payer dynamics.